IL-5 secretion by allergen-stimulated CD4+ T cells in primary culture: relationship to expression of allergic disease.

[1]  G. Canonica,et al.  Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing patients with symptomatic from patients with asymptomatic allergy to common aeroallergens. , 1995, The Journal of allergy and clinical immunology.

[2]  Y. Kawano,et al.  Modulation of mite antigen‐induced immune responses by lecithin‐bound iodine in peripheral blood lymphocytes from patients with bronchial asthma , 1995, British journal of pharmacology.

[3]  F. Simons,et al.  Allergen-stimulated interleukin-4 and interferon-gamma production in primary culture: responses of subjects with allergic rhinitis and normal controls. , 1995, Immunology.

[4]  C. Corrigan,et al.  Elevated interleukin‐4 secretion by T lymphocytes: a feature of atopy or of asthma? , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[5]  S. Durham,et al.  Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy. , 1995, American journal of respiratory cell and molecular biology.

[6]  S. Durham,et al.  Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. , 1995, American journal of respiratory cell and molecular biology.

[7]  O. Kaminuma,et al.  IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. , 1995, International immunology.

[8]  D. Umetsu,et al.  Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type , 1995, The Journal of experimental medicine.

[9]  D. Huston,et al.  Enhanced detection of human IL-5 in biological fluids utilizing murine monoclonal antibodies which delineate distinct neutralizing epitopes. , 1994, Cytokine.

[10]  C. Corrigan,et al.  Polymerase chain reaction quantification of cytokine messenger RNA expression in peripheral blood mononuclear cells of patients with acute exacerbations of asthma: effect of glucocorticoid therapy , 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  Y. Okubo,et al.  Cytokine production in patients with mite-sensitive bronchial asthma. , 1994, International archives of allergy and immunology.

[12]  D. Umetsu,et al.  In vitro synthesis of IL-4 by human CD4+ T cells requires repeated antigenic stimulation. , 1993, Cellular immunology.

[13]  T. Kamei,et al.  Production of interleukin-5 and granulocyte/macrophage colony-stimulating factor by T cells of patients with bronchial asthma in response to Dermatophagoides farinae and its relation to eosinophil colony-stimulating factor. , 1993, American journal of respiratory cell and molecular biology.

[14]  S. Durham,et al.  Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. , 1993, The Journal of allergy and clinical immunology.

[15]  V. Brusasco,et al.  Frequency of allergen-specific T lymphocytes in blood and bronchial response to allergen in asthma. , 1993, The Journal of allergy and clinical immunology.

[16]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[17]  R. V. van Lier,et al.  Human atopen-specific types 1 and 2 T helper cell clones. , 1991, Journal of immunology.

[18]  Roberta,et al.  Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. , 1991, The Journal of clinical investigation.

[19]  M. Piccinni,et al.  Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A J Wardlaw,et al.  Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. , 1991, The Journal of clinical investigation.

[21]  A. Wardlaw,et al.  IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. , 1990, Immunology.

[22]  W. Owen,et al.  IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. , 1989, Journal of immunology.

[23]  J. Gamble,et al.  Recombinant human interleukin 5 is a selective activator of human eosinophil function , 1988, The Journal of experimental medicine.

[24]  T. Platts-Mills,et al.  T cell responses to the major allergen from the house dust mite Dermatophagoides pteronyssinus, Antigen P1: comparison of patients with asthma, atopic dermatitis, and perennial rhinitis. , 1984, Journal of immunology.

[25]  E. Todd,et al.  Expression of terminal deoxynucleotidyl transferase in human thymus during ontogeny and development. , 1983, Journal of immunology.